Klinische Monatsblatter fur Augenheilkunde · 1999
[Results after cyclodiathermy: report on 29 eyes].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kloevekorn-Norgall C, Groh M J, Küchle M, Naumann G O
Аннотация
BACKGROUND: Persisting angle-closure glaucomas with circular anterior synechia and lost anterior chamber are at the moment an unsolved therapeutical problem. Antiglaucomatous anterior cyclodiathermy is a last therapeutical option to serve the eye.
PATIENTS AND METHODS: We retrospectively examined the results and the complications of 29 eyes, which were consecutively treated with anterior cyclodiathermy between 1992 and 1998.
RESULTS: We found a significant decrease of the intraocular pressure (IOP) during mean follow-up of 10 month, reduction of antiglaucoma medication, no change of visual acuity and no severe complications (no phthisis bulbi, no severe intraocular hemorrhage, no sympathetic ophthalmia).
CONCLUSION: Anterior cyclodiathermy is a successful treatment for selected patients with severe forms of glaucoma, if other operation techniques and antiglaucoma medication fail to decrease the IOP.
PATIENTS AND METHODS: We retrospectively examined the results and the complications of 29 eyes, which were consecutively treated with anterior cyclodiathermy between 1992 and 1998.
RESULTS: We found a significant decrease of the intraocular pressure (IOP) during mean follow-up of 10 month, reduction of antiglaucoma medication, no change of visual acuity and no severe complications (no phthisis bulbi, no severe intraocular hemorrhage, no sympathetic ophthalmia).
CONCLUSION: Anterior cyclodiathermy is a successful treatment for selected patients with severe forms of glaucoma, if other operation techniques and antiglaucoma medication fail to decrease the IOP.